BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25119594)

  • 1. Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span.
    Amer M; Elhefnawi M; El-Ahwany E; Awad AF; Gawad NA; Zada S; Tawab FM
    Tumour Biol; 2014 Nov; 35(11):11301-9. PubMed ID: 25119594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation.
    Sambri I; Capasso R; Pucci P; Perna AF; Ingrosso D
    J Biol Chem; 2011 Dec; 286(51):43690-43700. PubMed ID: 22033921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
    Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA
    Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
    Lin J; Huang S; Wu S; Ding J; Zhao Y; Liang L; Tian Q; Zha R; Zhan R; He X
    Carcinogenesis; 2011 Nov; 32(11):1641-7. PubMed ID: 21890460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer.
    Liu J; Liu B; Li Y; Mi Z; Tan H; Rong P
    Eur J Med Res; 2023 Aug; 28(1):289. PubMed ID: 37596654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.
    Wen J; Xiong K; Aili A; Wang H; Zhu Y; Yu Z; Yao X; Jiang P; Xue L; Wang J
    Theranostics; 2020; 10(12):5322-5340. PubMed ID: 32373215
    [No Abstract]   [Full Text] [Related]  

  • 12. miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2.
    Zhang JJ; Wang CY; Hua L; Yao KH; Chen JT; Hu JH
    Int J Clin Exp Pathol; 2015; 8(5):5168-74. PubMed ID: 26191213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
    Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H; Ooi LL; Hui KM
    PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
    Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
    Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
    Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
    Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX
    Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.
    Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL
    Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.